{"id":8669,"date":"2021-12-17T01:52:52","date_gmt":"2021-12-17T06:52:52","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/glp-1-7-37-cas-106612-94-6-reduce-el-azucar-en-sangre-de-una-manera-dependiente-de-la-glucosa-sin-reacciones-adversas\/"},"modified":"2021-12-17T01:52:52","modified_gmt":"2021-12-17T06:52:52","slug":"glp-1-7-37-cas-106612-94-6-reduce-el-azucar-en-sangre-de-una-manera-dependiente-de-la-glucosa-sin-reacciones-adversas","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/es\/product\/glp-1-7-37-cas-106612-94-6-reduce-el-azucar-en-sangre-de-una-manera-dependiente-de-la-glucosa-sin-reacciones-adversas\/","title":{"rendered":"GLP-1 (7-37) CAS 106612-94-6 reduce el az\u00facar en sangre de una manera dependiente de la glucosa sin reacciones adversas"},"content":{"rendered":"

GLP-1 (7-37) CAS 106612-94-6 Niveles m\u00e1s bajos de glucosa en sangre sin efectos adversos<\/strong><\/h2>\n

Nombre del producto: H-HIS-ALA-GLU-GLY-THR-PHE-THR-SER-ASP-VAL-SER-SER-TYR-LEU-GLU-GLY-GLN-ALA-ALA-LYS-GLU- PHE-ILE-ALA-TRP-LEU-VAL-LYS-GLY-ARG-GLY-OH \/ GLP-1 (7-37)
\n Sin\u00f3nimos: Insulinotropina (humana); P\u00e9ptido GLP-1 (p\u00e9ptido reductor de glucosa humano -1); Glp-I (7-37); P\u00e9ptido similar al glucag\u00f3n I (7-37); P\u00e9ptido relacionado con el glucag\u00f3n (oncorhynchus kisutch), \u00e1cido 3-L-glut\u00e1mico-6-L-fenilalanina-9-L-asp\u00e1rtico \u00e1cido-12-L-serina-15-L-\u00e1cido glut\u00e1mico-16-glicina-21-L-isoleucina-24-L-alanina-27-L-valina-28-L-lisina-31-glicina-; Tglp- 1; GLP-1, 7-37; Preproglucagon 78-108
\n CAS: 106612-94-6
\n MF: C151H228N40O47
\n MW: 3355,67
\n EINECS:
\n Categor\u00edas de productos: p\u00e9ptidos farmac\u00e9uticos; p\u00e9ptido
\n Mol Archivo: 106612-94-6.mol <\/p>\n

GLP-1 (7-37) CAS 106612-94-6 Propiedades qu\u00edmicas<\/strong>
\n densidad 1,48 \u00b1 0,1 g \/ cm3 (previsto) < &> temperatura de almacenamiento \u221220 \u00b0 C
\n Solubilidad en agua Soluble en agua a 2 mg \/ ml
\n Referencia de la base de datos CAS 106612-94-6 <\/p>\n

Funci\u00f3n y aplicaci\u00f3n de GLP-1 (7-37) CAS 106612-94- 6<\/strong>
\n El p\u00e9ptido -1 similar al glucag\u00f3n humano (GLP-1) es un peque\u00f1o polip\u00e9ptido con 30 amino\u00e1cidos, que es potente para reducir el az\u00facar en sangre de una manera dependiente de la glucosa sin reacciones adversas, adem\u00e1s de las m\u00faltiples funciones del GLP-1 , se convierte en un foco de investigaci\u00f3n para curar la diabetesII. Sin embargo, para realizar su aplicaci\u00f3n cl\u00ednica, es urgente resolver el problema de su corta vida media in vivo. Por lo tanto, las revisiones de los \u00faltimos avances en la investigaci\u00f3n y la aplicaci\u00f3n cl\u00ednica de GLP-1 en China y en el extranjero sobre la base de estudios previos proporcionar\u00e1n una referencia para los investigadores y trabajadores m\u00e9dicos en el desarrollo de medicamentos relevantes para GLP-1.<\/p>\n","protected":false},"excerpt":{"rendered":"

Nombre del producto: H-HIS-ALA-GLU-GLY-THR-PHE-THR-SER-ASP-VAL-SER-SER-TYR-LEU-GLU-GLY-GLN-ALA-ALA-LYS-GLU-PHE-ILE -ALA-TRP-LEU-VAL-LYS-GLY-ARG-GLY-OH \/ GLP-1 (7-37)
\n CAS: 106612-94-6
\n MF: C151H228N40O47
\n MW: 3355,67 < &> Archivo Mol: 106612-94-6.mol<\/p>\n","protected":false},"featured_media":2300,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[],"product_tag":[1075],"class_list":{"0":"post-8669","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_tag-glp-1-7-37-cas-106612-94-6-reduce-blood-sugar-in-a-glucose-dependentmanner-without-any-adverse-reactions-es","7":"desktop-align-left","8":"tablet-align-left","9":"mobile-align-left","11":"first","12":"instock","13":"shipping-taxable","14":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/product\/8669","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/comments?post=8669"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/media\/2300"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/media?parent=8669"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/product_brand?post=8669"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/product_cat?post=8669"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/product_tag?post=8669"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}